Nachrichten zur Hims & Hers Health Inc. Aktie

Hims & Hers rose more than 27% on Thursday after Robert F. Kennedy was confirmed to lead the Department of…

Hims & Hers Health (NYSE:HIMS) Reaches New 1-Year High - Still a Buy?…

Retail investors are boosting Hims & Hers after the success of its Super Bowl ad Sunday.…

…

Novo Nordisk called out suppliers of compounded weight-loss drugs following Hims & Hers’ controversial Super Bowl ad.…

Hims & Hers Health (HIMS) stock hit a new all-time high on Thursday as retail investors have taken interest in…

Hims & Hers hit the bulls-eye with its Super Bowl ad—it sparked a lot of attention from consumers to check…

Telehealth company Hims & Hers stirred up controversy by debuting | Telehealth company Hims & Hers stirred up controversy by…

By: Katie Karlson and Madeline Darby Super Bowl commercials have been a cultural phenomenon for years. However, this year, one…

Hims & Hers faced backlash over its Super Bowl ad touting its compound weight loss drug while slamming pharmaceutical giants…

Big pharma tried to stop Hims & Hers Super Bowl ad.…

Big pharma tried to stop Hims & Hers Super Bowl ad.…

Novo Nordisk called out suppliers of compounded weight loss drugs following Hims & Hers’ controversial Super Bowl ad.…

We came across a bullish thesis on Hims & Hers Health, Inc. (HIMS) on Substack by Lorenzo’s 2 cents. In…

The supply shortage and high costs of GLP-1 weight loss drugs have created an opportunity for compounded GLP-1 treatments to hit…

Hims & Hers has shown impressive revenue growth, accelerating from 46% to 77%. Read why I downgrade HIMS stock from…

Hims & Hers sells a compounded weight loss medication.…

Okupe Oluyemi, Chief Financial Officer of Hims & Hers Health, sold 11,581 shares of Class A Common Stock on February…

Hims & Hers is under scrutiny for promoting compounded weight-loss drugs in a Super Bowl ad without clear FDA approval…

Novo Nordisk called out suppliers of compounded weight loss drugs following Hims & Hers’ controversial Super Bowl ad.…

Compounded weight-loss medications such as those promoted in the Hims & Hers commercial aren’t approved by the FDA.…

The tele-health company Hims & Hers Health is facing scrutiny after critics say its Super Bowl ad promotes weight loss…

Hims & Hers’ 2025 Super Bowl commercial generated plenty of c | Hims & Hers “Sick of the System” spot…

The recent Super Bowl advertisement by telehealth company Hims & Hers has sparked significant controversy, drawing eye-catching attention for its…

…

Hims & Hers future growth is expected from personalized solutions, with potential to expand the subscriber base by millions. Read…

The telehealth company Hims & Hers put out a Super Bowl ad that skimped on clarifying that its compounded semaglutide…

Two healthcare stocks in the white-hot weight-loss segment tanked on Monday as one of their rivals zoomed higher. The…